sac-TMT

Fierce Pharma

For Merck, 2027 is ‘another year of investment’

Merck sees 2027 “as another year of investment, as we invest behind our expansive pipeline and our new product launches,” CFO Caroline Litchfield said.

Angus Liu Oct 29, 2026 11:23am